HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LONGBIO-B

142.000

+0.1000.07%

Volume:13.05K

Turnover:1.86M

Market Cap:10.54B

PE:-51.96

High:143.600

Open:141.600

Low:141.400

Close:141.900

52wk High:158.000

52wk Low:116.100

Shares:74.19M

HK Float Shares:72.93M

Volume Ratio:0.18

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.733

ROE:--

ROA:-54.56%

PB:64.76

PE(LYR):-51.96

PS:- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

LONGBIO-B

Exchange:

SEHK

Establishment Date:

2020

Employees:

85

Office Location:

Building F, Area A,5th Floor,No. 128 Yinhe Road,Dongnan Subdistrict,Changshu,Jiangsu Province,China

Website:

http://www.longbio.com

Zip Code:

215500

Phone:

86 21 5837 2970

Fax:

- -

Introduction:

LongBio Pharma (Suzhou) Co Ltd is a China-based company primarily engaged in the in-house discovery and development of biopharmaceuticals targeting allergic and autoimmune diseases. The Company's main products include LP-003 and LP-005. LP-003 is targeted to treat allergic diseases, including seasonal AR, CSU, allergic asthma, food allergy and other allergic diseases. LP-005 is used for paroxysmal nocturnal hemoglobinuria (PNH), complement-mediated kidney diseases, which includes IgA nephropathy (IgAN), C3 glomerulopathy (C3G) and lupus nephritis (LN) and other complement related indications. The Company mainly operates its businesses in the domestic market.

Directors

Name

Position

LIU Heng

Chairman of the Board,Executive Director,Chairman of the Nomination Committee

SUN Nai Chao

Executive Director

XIE Ming

Executive Director,Member of the Remuneration and Assessment Committee

XIAO Yao Xi

Independent Director,Member of the Nomination Committee,Chairman of the Audit Committee

RUAN Tian Shi

Independent Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee

YANG Chun

Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee

ZHOU Guo Fang

Independent Director,Member of the Nomination Committee

LIN Jian

Director,Member of the Audit Committee

GU Qin

Director,Member of the Nomination Committee

XUE Di

Director

CHEN Kan

Director

Shareholders

Name

Position

LIU Heng

CEO,General Manager

XIE Ming

Vice General Manager

WENG Mei Yi

Corporate Secretary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01779/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01779","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","market":"HK","secType":"STK","nameCN":"LONGBIO-B","latestPrice":142,"timestamp":1781229006855,"preClose":141.9,"halted":0,"volume":13050,"delay":0,"changeRate":0.000704721634954153,"floatShares":72930300,"shares":74193200,"eps":-2.733,"marketStatus":"Trading","change":0.1,"latestTime":"06-12 09:50:42","open":141.6,"high":143.6,"low":141.4,"amount":1855855,"amplitude":0.015504,"askPrice":142,"askSize":200,"bidPrice":141.9,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-2.62,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1781236800000},"marketStatusCode":2,"adr":0,"listingDate":1780588800000,"exchange":"SEHK","adjPreClose":141.9,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.175997,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","floatShares":72930300,"roa":"-54.56%","roe":"--","lyrEps":-2.733,"volumeRatio":0.175997,"shares":74193200,"dividePrice":0,"high":143.6,"amplitude":0.015504,"preClose":141.9,"low":141.4,"week52Low":116.1,"pbRate":"64.76","week52High":158,"institutionHeld":0,"latestPrice":142,"committee":-0.6,"eps":-2.733,"divideRate":0,"volume":13050,"delay":0,"ttmEps":-2.62,"open":141.6,"prevYearClose":96.06,"prevWeekClose":131.8,"prevMonthClose":96.06,"prevQuarterClose":96.06,"fiveDayClose":131.8,"twentyDayClose":96.06,"sixtyDayClose":96.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01779\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01779\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01779\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01779\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01779","date":"2026-06-11","current":-54.503817,"percent":0,"low":-51.840962,"twenty":-51.375989,"median":-50.647492,"eighty":-48.25779,"high":-45.301009,"avg":-49.609239,"sd":2.551846,"marketCap":10528007985},"quantilePoints":[{"date":"2026-06-11","current":-51.840962,"twenty":-51.375989,"median":-50.647492,"eighty":-48.25779,"marketCap":10528007985}],"updateTime":1781228971624},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1797221674,"yearFounded":2020,"employeeNum":85,"address":"Building F, Area A,5th Floor,No. 128 Yinhe Road,Dongnan Subdistrict,Changshu,Jiangsu Province,China","zipCode":"215500","officePhone":"86 21 5837 2970","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.longbio.com","stockEarnings":[{"period":"1week","weight":0.4772},{"period":"ytd","weight":0.4772}],"compareEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.0665},{"period":"1year","weight":-0.0048},{"period":"ytd","weight":-0.0539}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"LongBio Pharma (Suzhou) Co Ltd is a China-based company primarily engaged in the in-house discovery and development of biopharmaceuticals targeting allergic and autoimmune diseases. The Company's main products include LP-003 and LP-005. LP-003 is targeted to treat allergic diseases, including seasonal AR, CSU, allergic asthma, food allergy and other allergic diseases. LP-005 is used for paroxysmal nocturnal hemoglobinuria (PNH), complement-mediated kidney diseases, which includes IgA nephropathy (IgAN), C3 glomerulopathy (C3G) and lupus nephritis (LN) and other complement related indications. The Company mainly operates its businesses in the domestic market.","exchange":"SEHK","name":"LONGBIO-B","nameEN":"LONGBIO-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"01779\",market:\"HK\",,,undefined,":{"directors":[{"name":"LIU Heng","position":"Chairman of the Board,Executive Director,Chairman of the Nomination Committee"},{"name":"SUN Nai Chao","position":"Executive Director"},{"name":"XIE Ming","position":"Executive Director,Member of the Remuneration and Assessment Committee"},{"name":"XIAO Yao Xi","position":"Independent Director,Member of the Nomination Committee,Chairman of the Audit Committee"},{"name":"RUAN Tian Shi","position":"Independent Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee"},{"name":"YANG Chun","position":"Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee"},{"name":"ZHOU Guo Fang","position":"Independent Director,Member of the Nomination Committee"},{"name":"LIN Jian","position":"Director,Member of the Audit Committee"},{"name":"GU Qin","position":"Director,Member of the Nomination Committee"},{"name":"XUE Di","position":"Director"},{"name":"CHEN Kan","position":"Director"}],"executives":[{"name":"LIU Heng","position":"CEO,General Manager"},{"name":"XIE Ming","position":"Vice General Manager"},{"name":"WENG Mei Yi","position":"Corporate Secretary"}]}}}